Insider Transactions in Q3 2025 at Guardant Health, Inc. (GH)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 17
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-1.56%
|
$5,568
$48.2 P/Share
|
|
Jul 17
2025
|
Medina Manuel Hidalgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,784
+50.0%
|
-
|
|
Jul 17
2025
|
Myrtle S Potter Director |
SELL
Open market or private sale
|
Direct |
26
-0.14%
|
$1,248
$48.2 P/Share
|
|
Jul 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.37%
|
-
|
|
Jul 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+3.25%
|
-
|
|
Jul 04
2025
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.59%
|
-
|
|
Jul 01
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,365
-6.24%
|
$68,250
$50.71 P/Share
|
|
Jul 01
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,691
+5.95%
|
-
|
|
Jul 01
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,386
-3.0%
|
$69,300
$50.71 P/Share
|
|
Jul 01
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,641
+2.81%
|
-
|
|
Jul 01
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,057
-2.4%
|
$52,850
$50.71 P/Share
|
|
Jul 01
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,084
+4.51%
|
-
|
|
Jul 01
2025
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,525
-1.84%
|
$76,250
$50.71 P/Share
|
|
Jul 01
2025
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,007
+1.8%
|
-
|
|
Jul 01
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,714
-4.45%
|
$85,700
$50.71 P/Share
|
|
Jul 01
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,381
+4.3%
|
-
|
|
Jul 01
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,532
-3.04%
|
$76,600
$50.71 P/Share
|
|
Jul 01
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,596
+3.51%
|
-
|
|
Jul 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,162
-0.5%
|
$608,100
$50.71 P/Share
|
|
Jul 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,997
+0.98%
|
-
|
|
Jul 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,162
-0.61%
|
$608,100
$50.71 P/Share
|
|
Jul 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,997
+1.19%
|
-
|
|
Jul 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-2.44%
|
$5,100,000
$51.04 P/Share
|